tiprankstipranks
Trending News
More News >
Scandion Oncology A/S (DE:8VY)
:8VY
Germany Market

Scandion Oncology A/S (8VY) Income Statement

Compare
0 Followers

Scandion Oncology A/S Income Statement

Last quarter (Q3 2024), Scandion Oncology A/S's total revenue was kr0.00, a decrease of ― from the same quarter last year. In Q3, Scandion Oncology A/S's net income was kr-6.75M. See Scandion Oncology A/S’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
kr 0.00kr 0.00kr 0.00kr 0.00kr 205.44K
Gross Profit
kr 0.00kr 0.00kr 0.00kr 0.00kr -11.16M
Operating Expenses
kr 45.36Mkr 80.17Mkr 55.37Mkr 22.89Mkr 15.40M
Depreciation and Amortization
kr 271.00Kkr 882.00Kkr 604.00Kkr 281.00Kkr -7.14K
EBITDA
kr -45.53Mkr -80.82Mkr -56.10Mkr -22.85Mkr -15.60M
Operating Income
kr -45.36Mkr -80.17Mkr -55.37Mkr -22.89Mkr -15.39M
Other Income/Expenses
kr 653.00Kkr -2.03Mkr -1.85Mkr 1.37Mkr 49.00K
Pretax Income
kr -44.70Mkr -82.20Mkr -57.21Mkr -20.65Mkr -15.55M
Net Income
kr -39.20Mkr -76.70Mkr -51.70Mkr -16.27Mkr -12.18M
Per Share Metrics
Basic EPS
kr -0.96kr -1.79kr -1.61kr -0.51kr -0.81
Diluted EPS
kr -0.96kr -1.79kr -1.54kr -0.50kr -0.81
Weighted Average Shares Outstanding
40.71M 42.93M 32.14M 32.14M 15.05M
Weighted Average Shares Outstanding (Diluted)
40.71M 42.93M 33.64M 32.32M 15.05M
Currency in DKK

Scandion Oncology A/S Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis